Finally out!
The Basis for Future Personalized Therapy Approaches - Machine Learning-Generated 1-Year Survival Rate, Metastatic Status and Therapy-dependent Survival in Pancreatic Cancer Patients - European Journal of Cancer https://t.co/nIXUIFiewq
🎖️Gratulation an Dr. Daniel Nörenberg! Der #CharitéBerlin-Onkologe wurde von der German Lymphoma Alliance für seine Arbeit zu primären mediastinalen B-Zell-Lymphomen ausgezeichnet – eine Krebserkrankung, die v.a. junge Frauen betrifft. https://t.co/X2bhWpoPrt
🎖️Gratulation an Dr. Daniel Nörenberg! Der #CharitéBerlin-Onkologe wurde von der German Lymphoma Alliance für seine Arbeit zu primären mediastinalen B-Zell-Lymphomen ausgezeichnet – eine Krebserkrankung, die v.a. junge Frauen betrifft. https://t.co/X2bhWpoPrt
Baseline Liquid Biopsy in Relation to Tissue-Based Parameters in Metastatic Colorectal Cancer: Results From the Randomized FIRE-4 (AIO-KRK-0114) Study | Journal of Clinical Oncology https://t.co/dopqf7UhQW
The SAGITTARIUS clinical trial will use personalised liquid biopsy tests to personalise the management & therapy of patients with high-risk stage II or operable stage III colon cancer. It will include 4 experimental arms.
More: https://t.co/8TMLQSUUKY
🎉 The SAGITTARIUS trial first patient is now enrolled!
This marks a significant milestone in this project, which aims to revolutionise colon cancer treatment.
Find out more and stay tuned for updates: https://t.co/8TMLQSUUKY 🌐
#CRC#EUCancerMission#SagittariusEU
Outstanding presentation by @JenSeligmann at #ESMOGI24 about neoadj strategies to modify the status quo in localized colon cancer. Academic research will be the key, sure! 💪🏻 @myESMO #ESMOAmbassadors
🔊On this #WorldDigestiveHealthDay, let's make digestive health a priority!
The #SAGITTARIUSproject is exploring liquid biopsy to detect colon cancer signs post-surgery. This personalized approach aims to enhance post-surgical treatment compared to standard methods.✨
Tomorrow the @OncoAlert 🚨 Newsletter will be out!
There are some really 🔥 news, so if you don’t receive it yet, there is still time to sign up!
Especially important in my opinion are the @ASCO guidelines on drug shortages in #oncology ‼️
FIRE 🔥 Treffen im Rahmen des @AIO_Onkologie Herbstkongress! @ArndtStahler @heinrich_kat@BenWestphalen
Studien für Patienten von Klinikern! Die Therapie optimieren!
Today, we were at SAGITTARIUS kick-off meeting in Milan 🇮🇹! Our role in the project is to represent the patient's perspective in the clinical trial's design & execution. Additionally, we'll ensure effective communication & dissemination to maximise project impact. #SagittariusEU
Welcome to the SAGITTARIUS kick-off meeting! SAGITTARIUS is an international research project aimed at optimising clinical management of locoregional stage II high-risk/stage III colon cancer through an innovative precision medicine approach.
#SagittariusEU#eucanbeatcancer
Save the date for the ESMO Gastrointestinal Cancers Congress 2024, on 26-29 June, in Munich, Germany. Be ready to share your latest studies on effectively implementing recent discoveries to improve the lives of patients w/ #GIcancers. https://t.co/u12KvDaGXA #ESMOGI24 @DucreuxMichel @MacarullaTeresa